A detailed history of Citigroup Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Citigroup Inc holds 597,706 shares of ZTS stock, worth $109 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
597,706
Previous 743,080 19.56%
Holding current value
$109 Million
Previous $126 Million 17.59%
% of portfolio
0.07%
Previous 0.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$145.54 - $178.83 $21.2 Million - $26 Million
-145,374 Reduced 19.56%
597,706 $104 Million
Q1 2024

May 10, 2024

BUY
$165.67 - $199.94 $9.46 Million - $11.4 Million
57,073 Added 8.32%
743,080 $126 Million
Q4 2023

Feb 09, 2024

BUY
$151.44 - $200.09 $2.45 Million - $3.24 Million
16,191 Added 2.42%
686,007 $135 Million
Q3 2023

Nov 09, 2023

BUY
$167.14 - $192.77 $26.3 Million - $30.3 Million
157,296 Added 30.69%
669,816 $117 Million
Q2 2023

Aug 10, 2023

BUY
$160.94 - $186.23 $4.43 Million - $5.12 Million
27,505 Added 5.67%
512,520 $88.3 Million
Q1 2023

May 11, 2023

BUY
$145.48 - $175.02 $8.57 Million - $10.3 Million
58,879 Added 13.82%
485,015 $80.7 Million
Q4 2022

Feb 09, 2023

SELL
$131.14 - $157.47 $31.3 Million - $37.5 Million
-238,386 Reduced 35.87%
426,136 $62.5 Million
Q3 2022

Nov 10, 2022

BUY
$148.29 - $182.55 $16.8 Million - $20.7 Million
113,295 Added 20.55%
664,522 $98.5 Million
Q2 2022

Aug 10, 2022

BUY
$155.97 - $200.09 $9.46 Million - $12.1 Million
60,626 Added 12.36%
551,227 $94.8 Million
Q1 2022

May 12, 2022

BUY
$181.39 - $234.03 $10.1 Million - $13.1 Million
55,794 Added 12.83%
490,601 $92.5 Million
Q4 2021

Feb 10, 2022

SELL
$193.69 - $247.03 $10.7 Million - $13.7 Million
-55,411 Reduced 11.3%
434,807 $106 Million
Q3 2021

Nov 10, 2021

BUY
$189.29 - $209.69 $92.8 Million - $103 Million
490,218 New
490,218 $95.2 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $85.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.